+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5189457
  • Report
  • October 2020
  • Region: Global
  • 221 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AFYX Therapeutics A/S
  • BioXcel Therapeutics Inc
  • Ghent University
  • Lyra Therapeutics
  • Nanosys Inc
  • Rhinomed Limited
  • MORE
Summary

The publisher's Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020“. Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane. Usually, drugs are administered through buccal, rectal, vaginal, and nasal routes.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transmucosal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transmucosal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transmucosal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AFYX Therapeutics A/S
  • BioXcel Therapeutics Inc
  • Ghent University
  • Lyra Therapeutics
  • Nanosys Inc
  • Rhinomed Limited
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Transmucosal Drug Delivery Overview

3 Products under Development
3.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
3.2 Transmucosal Drug Delivery - Pipeline Products by Segment
3.3 Transmucosal Drug Delivery - Pipeline Products by Territory
3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials

4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies
4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development

5 Transmucosal Drug Delivery Companies and Product Overview

6 Transmucosal Drug Delivery- Recent Developments 1607 Appendix

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Table 2: Transmucosal Drug Delivery - Pipeline Products by Segment
Table 3: Transmucosal Drug Delivery - Pipeline Products by Territory
Table 4: Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
Table 5: Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
Table 6: Transmucosal Drug Delivery - Ongoing Clinical Trials
Table 7: Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
Table 8: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Table 9: AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: ZALVISO - Product Status
Table 11: ZALVISO - Product Description
Table 12: AcelRx Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 13: ZALVISO - Treatment of Acute Post-operative Pain in Patients Undergoing Laparoscopic Colon Resections
Table 14: ZALVISO - Usability and Satisfaction Evaluation of Sufentanil Sublingual Patient-controlled Analgesia after Elective Surgery with Moderate-to-severe Postoperative Pain
Table 15: AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Rivelin Combo Patch - Product Status
Table 17: Rivelin Combo Patch - Product Description
Table 18: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Drug-Impregnated Intravaginal Ring - Product Status
Table 20: Drug-Impregnated Intravaginal Ring - Product Description
Table 21: Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Vaginal Ring Contraceptive - Product Status
Table 23: Vaginal Ring Contraceptive - Product Description
Table 24: Amphastar Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Intranasal Naloxone Spray - Product Status
Table 26: Intranasal Naloxone Spray - Product Description
Table 27: Anelleo Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: AnelleO PRO - Product Status
Table 29: AnelleO PRO - Product Description
Table 30: ARS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: ARS-1 - Product Status
Table 32: ARS-1 - Product Description
Table 33: Auris Medical AG Pipeline Products & Ongoing Clinical Trials Overview
Table 34: AM-125 Betahistine Nasal Spray - Product Status
Table 35: AM-125 Betahistine Nasal Spray - Product Description
Table 36: AM-201 Betahistine Nasal Spray - Product Status
Table 37: AM-201 Betahistine Nasal Spray - Product Description
Table 38: AM-301 Nasal Spray - Product Status
Table 39: AM-301 Nasal Spray - Product Description
Table 40: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Versa Intravaginal Ring - Acromegaly - Product Status
Table 42: Versa Intravaginal Ring - Acromegaly - Product Description
Table 43: Versa Intravaginal Ring - Alzheimer's Disease - Product Status
Table 44: Versa Intravaginal Ring - Alzheimer's Disease - Product Description

List of Figures
Figure 1: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Figure 2: Transmucosal Drug Delivery - Pipeline Products by Segment
Figure 3: Transmucosal Drug Delivery - Pipeline Products by Territory
Figure 4: Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
Figure 5: Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
Figure 6: Transmucosal Drug Delivery - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • AcelRx Pharmaceuticals Inc
  • AFYX Therapeutics A/S
  • Albert Einstein College of Medicine
  • Allergan Ltd
  • Amphastar Pharmaceuticals Inc
  • Anelleo Inc
  • ARS Pharmaceuticals Inc
  • Auris Medical AG
  • Auritec Pharmaceuticals Inc
  • BeFree!
  • Bespak Europe Ltd
  • Biorings LLC
  • BioXcel Therapeutics Inc
  • Bryn Pharma LLC
  • Callitas Therapeutics Inc
  • Combinent BioMedical Systems Inc
  • Conrad
  • Dare Bioscience Inc
  • Emergent BioSolutions Inc
  • Evestra Inc
  • Evoke Pharma Inc
  • EyeGate Pharmaceuticals Inc
  • Ferring Pharmaceuticals AS
  • Ghent University
  • Glenmark Pharmaceuticals Ltd
  • Grunenthal Ltd
  • Hebrew University of Jerusalem
  • Hikma Pharmaceuticals Plc
  • INSYS Therapeutics Inc
  • IntelGenx Corp
  • ITF Pharma Inc
  • Janssen Sciences Ireland UC
  • Karessa Pharma AB
  • Kytogenics Pharmaceuticals Inc
  • Laboratoire HRA Pharma SAS
  • Laboratorios Andromaco
  • Lyra Therapeutics
  • McNeil AB
  • Medlab Clinical Ltd
  • Merck & Co Inc
  • Merck Serono SA
  • Merck Sharp & Dohme Ltd
  • Mithra Pharmaceuticals SA
  • Mucommune LLC
  • Mystic Pharmaceuticals Inc
  • Nanosys Inc
  • NorInvent AB
  • Novus Therapeutics Inc
  • Oak Crest Institute of Science
  • Opiant Pharmaceuticals Inc
  • OptiNose AS
  • OptiNose Inc
  • Orion Biotechnology Canada Ltd
  • Orphanse Healthcare SAS
  • Palette Life Sciences AB
  • Phoenix Life Sciences International Ltd
  • RDD Pharma Ltd
  • Renown Pharmaceuticals Pvt Ltd
  • Rhinomed Limited
  • Scientus Pharma Inc
  • Seelos Therapeutics, Inc.
  • Shin Nippon Biomedical Laboratories Ltd
  • Starpharma Holdings Ltd
  • Suda Pharmaceuticals Ltd
  • The Hong Kong University of Science and Technology
  • Therakind Ltd
  • University of Pittsburgh
  • University of South Florida
  • University of Texas at Austin
  • University of the Witwatersrand
  • University of Washington
  • Washington University in St Louis
  • Zosano Pharma Corp
Note: Product cover images may vary from those shown
Adroll
adroll